Mankind Pharma Ltd (MANKIND) — Financial Flexibility Index

Latest as of September 2023: 0.08x

Mankind Pharma Ltd (MANKIND) has a Financial Flexibility Index of 0.08x as of September 2023. Free cash flow of Rs1.93 Billion (operating CF Rs1.93 Billion minus capex Rs0.00) represents 0% of total liabilities (Rs24.65 Billion). Check Mankind Pharma Ltd liquid asset ratio to evaluate the company's liquid asset resilience ratio.

Financial Flexibility Index

0.08x
Free Cash Flow / Total Liabilities

Free Cash Flow

Rs1.93 Billion
Operating CF − Capex

Total Liabilities

Rs24.65 Billion
INR

Capital Expenditures

Rs0.00
INR

Mankind Pharma Ltd Financial Flexibility Index (2019–2025)

Historical Financial Flexibility Index trend for Mankind Pharma Ltd across 7 annual periods. See Mankind Pharma Ltd current assets vs equity to evaluate short-term liquidity relative to the company's equity base.

Annual Financial Flexibility Index for Mankind Pharma Ltd (2019–2025)

Year-by-year free cash flow to debt coverage for Mankind Pharma Ltd. For the full company profile including market capitalisation, see Mankind Pharma Ltd stock valuation.

Year Flexibility Index Free Cash Flow (INR) Operating CF Total Liabilities YoY Change
2025 0.22x Rs28.74 Billion Rs24.13 Billion Rs131.91 Billion ▼ -79.5%
2024 1.06x Rs25.35 Billion Rs21.52 Billion Rs23.87 Billion ▼ -17.1%
2023 1.28x Rs26.45 Billion Rs18.13 Billion Rs20.67 Billion ▲ +11.0%
2022 1.15x Rs32.65 Billion Rs9.20 Billion Rs28.31 Billion ▲ +20.1%
2021 0.96x Rs14.50 Billion Rs11.37 Billion Rs15.10 Billion ▲ +3.7%
2020 0.93x Rs12.98 Billion Rs10.70 Billion Rs14.02 Billion ▲ +16.6%
2019 0.79x Rs8.98 Billion Rs6.00 Billion Rs11.31 Billion
Financial Flexibility Index = (Operating CF − Capex) / Total Liabilities = Free Cash Flow / Total Liabilities